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INTRODUCTION 
I. THE HISTORY OF FIBRINOLYSIS 
Fibrinolysis has become a subject of increasing interest during 
recent years. A review by Astrup (1) describes current investiga¬ 
tions concerning "Fibrinolysis in the Organism." However, the pro¬ 
cess by which the human organism dissolves blood clots and disposes 
of fibrin deposits has puzzled man for quite some time. In a dis¬ 
cussion of "The Streptokinase-Plasminogen System" (4), Christensen 
has summarized the historical development of this subject. In this 
review, Christensen states that it is probable that the observation 
that clotted blood could spontaneously reliquify is as old as know¬ 
ledge of the clotting phenomenon itself. He cites Favre-Gilly's 
account (16) of what was probably the first experimental production 
of this lysis: in 1836 Denis de Coumercy observed that fibrin clots 
placed in salt solution would dissolve; varying concentrations of 
other salts were found to produce this effect. Although the phen¬ 
omenon was originally thought to represent a specific re-solution of 
the fibrin in the salts, later workers showed that the fibrin ac¬ 
tually underwent an irreversible change with the formation of new 
products (11, 12, 18, 21, 33). It was Dastre' (11-13) who origin¬ 
ally described the proteolytic activity of the serum. He introduced 
the term "fibrinolysis", since he considered the reaction to be 
analogous to the lysis of a fibrin clot by trypsin. 
The spontaneous fibrinolysis observed by these early authors 
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was a slow process, lasting over twenty-four hours, and often going 
on for days. The interesting observation that exposure to chloro¬ 
form would markedly hasten the spontaneous lysis heretofore observed 
was first made by Denys and de Marbaix (16). In 1903, Delezene and 
Pozerski (14-16) extended this observation. They showed that plasma 
treated with chloroform would develop not only enough fibrinolytic 
activity to lyse clots, but also enough to produce detectable diges¬ 
tion of casein and gelatin. This, then, introduced the concept of 
proteolytic activity and its relationship to fibrinolysis. Dele- 
zenne and Pozerski also noted that the addition of fresh serum to 
the chloroform treated serum resulted in decreased proteolytic ac¬ 
tivity, thus indicating the existence of protease inhibitors in 
intact serum. The concept of protease inhibitors is an important 
one, and has been well discussed by Grob in a comprehensive review 
of the literature (19). 
At about the time that Delezenne and Pozerski published their 
results, Hedin described a proteolytic enzyme which he had precipi¬ 
tated from ox serum with tannic acid (20). This enzyme was contained 
in the globulin fraction of serum, and did not digest either the glob¬ 
ulin itself or coagulated egg albumin. It acted on casein, gelatin, 
and coagulated ox serum. It was destroyed by heating to 55° for half 
an hour. 
Shortly after the discovery that chloroform increased the 
proteolytic activity of serum, other activators were described. 
Thus, Yamakawa in 1918 activated serum with organic solvents and 
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also by dialysis (49), Opie and Barker in 1908 by acid precipi¬ 
tation (54), and jUhling and Walisch by treatment with organic 
compounds such as urea, benzoate, and thiocyanates (24). Other 
investigators used cresols (56), kaolin, starch, and agar (22), 
and protamine (59). 
Tillet and Garner, in 1935, noted that sterile, cell-free 
filtrates of broth of hemolytic streptococci derived from patients 
were capable of rapidly liquifying normal human fibrin clots (42). 
The degree of activity of the filtrates paralleled the activity 
of whole broth cultures sufficiently closely to indicate that large 
amounts of the fibrinolytic substance were freely excreted into the 
surrounding medium. They named this streptococcal product "fibrino- 
lysin." Tillet and Garner also noted that the plasma of many patients 
recovering from acute hemolytic streptococcal infections, when clot¬ 
ted in the presence of active cultures, was highly resistant to fibrin¬ 
olysis. Furthermore, serum derived from patients whose plasma clot 
was resistant to the fibrinolysis often conferred an antifibrinolytic 
property on normal fibrin clots (42). 
In 1941 Milstone showed that if fibrinogen and thrombin were 
washed free of any traces of plasma, the resultant clot would not be 
lysed by Tillet?s "fibrinolysin" (30). He concluded that there was 
a "lytic factor" present in the euglobulin fraction of human serum, 
which, acting conjointly with the streptococcal product, attacked a 
given part of the fibrin clot. 
The findings of Milstone were confirmed by Christensen (2), 
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who went on to state that fibrinolysis is probably incident to 
proteolysis of the fibrin molecule. He studied the interaction 
between "lysin factor" and "fibrinolysin" before the appearance 
of proteolytic activity and stated that one of these components 
was necessary to activate the other. He found that in the presence 
of excess "fibrinolysin" the proteolytic activity developed was 
directly proportional to the concentration of "lysin factor" in 
the system, and concluded that "lysin factor" was the component 
which wad converted to a proteolytic enzyme. He enforced his 
hypothesis by showing that, although "lysin factor" preparations 
might develop proteolytic activity spontaneously, "fibrinolysin" 
solutions never did. In addition, treatment of a constant amount 
of "lysin factor" with varying amounts of "fibrinolysin" resulted 
in the eventual liberation of an equal amount of proteolytic activity 
in each instance, and the rate of activation was proportional to 
the "fibrinolysin" concentration. He suggested that "lysin factor" 
represented an inactive proteolytic enzyme or "zymogen" of serum 
which was activated by "fibrinolysin." He stated that the reaction 
resembled the chymotrypsin-trypsinogen system more than the tryp- 
sinogen-=enterokinase system, in that the activation did not appear 
to be rapidly autocatalytic as in the latter. Christensen stated 
that "demonstration of the action of streptococcal fibrinolysin 
and lysin factor on substrates other than fibrin or fibrinogen made 
it obvious that the specific designation ’fibrinolysin® for this 
component of streptococcal culture filtrates was inaccurate" (5). 
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And so, in 1944, Christensen and MacLeod (5) proposed a change in 
terminology, and introduced the nomenclature which is fairly well 
accepted today. Under their scheme, the activated enzyme is termed 
"plasmin," in conformity with common uses for proteases, where the 
prefix indicates the source of the enzyme, followed by -in. The 
inactive zymogen as it occurs in serum or plasma is designated as 
"plasminogen” to indicate its source, the plasma, and also to 
indicate that it is in an inactive precursor state. Streptococcal 
fibrinolysin is termed "streptokinase," analogous to"enterokinase." 
The activation scheme of 1947 (1) summarized the scientific 
thought on fibrinolysis at that time: 
PLASMINOGEN 
(precursor in blood) 
(activation) 
PLASMIN 
(protease) 
SPONTANEOUS 
CHLOROFORM 
STREPTOKINASE 
TISSUE ACTIVATOR 
("FIBRINOKINASE") 
After the above activation scheme was proposed, the question 
as to the mechanism of this activation naturally followed. There 
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were two main schools of thought. Christensen and MacLeod (5) held 
that plasminogen was an inactive zymogen form of the enzyme, con¬ 
verted to plasmin by the catalytic action of streptokinase, just 
as trypsinogen is converted to trypsin by enterokinase. This hypo¬ 
thesis was based on the study of the kinetics of the reaction. 
Studies by Kaplan (25), and Remmert and Cohen (38) tended to sub¬ 
stantiate this conclusion. Ratnoff, on the other hand, held that 
the reaction between streptokinase (SK) and plasminogen was a stoi¬ 
chiometric one (37). This theory was based largely on the observa¬ 
tion that the amount of final activity obtained in a reaction mix¬ 
ture is a function of the SK concentration. This view was confirmed 
by Wasserman (48), who demonstrated that the amount of plasmin 
formed from an excess of plasminogen by SK is dependent on the SK 
concentration. At all levels of SK, maximal plasmin formation 
occurred almost instantaneously, and did not increase with pro¬ 
longed incubation. He observed no autocatalytic conversion of 
plasminogen to plasmin. A definite ratio was found to exist be¬ 
tween the concentration of SK used and the plasmin formed. This 
ratio varied with the SK preparation. 
As more work was done in the investigation of the activation 
of plasminogen, it became apparant that the simple activation theory 
of 1947 was inadequate. For one thing, it failed to explain why 
SK had no effect on non-human plasminogen (33). In the presence of 
traces of human plasma or plasminogen, however, SK is quite effective 
in converting animal plasminogen to plasmin. In order to explain 
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79 
this, and other questions, Mullertz and Lassen, in 1955, proposed 
a new activation mechanism (32). They suggested that SK trans¬ 
formed a proactivator in human blood to an activator, which in 
turn converted the plasminogen of any species to plasmin? 
PROACTIVATOR 4 SK-► ACTIVATOR 
(SK-X) 
PLASMINOGEN 
(all species) 
— 
PLASMIN 
Astrup has outlined the above scheme in more detail as follows (1): 
PLASMINOGEN -► PLASMIN 
(activation of 
plasminogen) 
ACTIVATORS OF PLASMINOGEN 
(PLASMINOGENASES?) 
SPONTANEOUS 
CHLOROFORM 
TRYPSIN 
TISSUE ACTIVATOR 
ACTIVATOR IN URINE 
ACTIVATOR IN BLOOD, MILK, ETC. 
LYSOKINASES 
(SPONTANEOUS 
STREPTOKINASE 
KINASE IN BLOOD 
TISSUE KINASE 
- 
(activation of 
proactivator) 
PROACTIVATOR IN BLOOD, MILK, ETC 
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M&llertz and Lassen postulated that a low content of plasmino¬ 
gen proactivator in bovine blood was the reason for the incomplete 
activation of preparations of bovine blood by SK. In human plasma, 
a large excess of proactivator would permit an excess of universal 
activator to be formed by SK. This activator could convert bovine 
plasminogen to plasmin. 
In 1954, Sherry independently commented on the impurity of 
the clots used in the fibrinolytic assay. He stated that ,9The 
extraordinary fibrinolytic activity of SK activated human plasminogen, 
when measured with the conventional bovine clot, is due to the action 
of a contaminating bovine plasminogen in the fibrinogen preparation 
used in the assay system. This contaminating plasminogen is rapidly 
activated by SK in the presence of trace amounts of human plasmino¬ 
gen or plasmin. The activation of the bovine plasminogen under these 
circumstances, results in abnormally high values for the fibrino¬ 
lytic activity of human plasmin preparations” (41). It has also been 
shown that the thrombin used in these early assays was contamina¬ 
ted with bovine plasminogen (28). Recently, a purified clot has 
been developed in which both the fibrinogen and thrombin are vir¬ 
tually free from contamination by bovine plasminogen, and which 
therefore can provide a true measure of the fibrinolytic activity 
of a substance (10). 
A later study by Mtillertz (51) further clarified the nature 
of the activation of plasminogen. He found that at suboptimal con¬ 
centrations of SK , only a partial conversion of proactivator to 
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activator was obtained, followed by a slow deterioration of the 
activator formed. The amount of activator formed in solutions 
containing varying proportions of proactivator and SK indicated 
a stoichiometric reaction proceeding to an equilibrium. Experi¬ 
ments on the effects of dilution suggested that SK and proacti¬ 
vator interacted to form two components, an activator and an in¬ 
active component. The activator was very labile at acid and al¬ 
kaline reactions, with an optimum stability between pH 6,5 and 
8.0, differing in this respect from other known components of the 
proteolytic enzyme system in blood. 
Not all investigators accept the concept of a proactivator 
as proposed by Astnip. Except by indirect inference, the exist¬ 
ence of a proactivator has not as yet been demonstrated. Sherry, 
who originally felt that proactivator and plasminogen were identi¬ 
cal (41), came to accept Astrup9 s postulate of a separate pro¬ 
activator as a result of work which he reported in 1955 (44)• 
Working with lysine and arginine esters as substrates for measuring 
proteolytic activity, which, he assumed, was equal or proportional 
to fibrinolytic activity, he demonstrated that two factors were 
produced by the activation of human plasminogen by SK. He described 
the "stoichiometric" interaction of SK and a "plasma factor" (pro¬ 
activator) to form an activator, and the enzymatic activation of 
plasminogen by this activator to form plasmin. Although plasmin 
split both lysine and arginine esters, activator split only lysine 
esters. Hence, Sherry concluded that he was dealing with two discrete 
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substances. However, recent work by Hagan, Ablondi, and Hutchins, 
who are said to have discovered an artifact in the synthetic sub¬ 
strate experiments (55), and by Kline (28), strongly suggests that 
proactivator and plasminogen are the same substance. Sherry now 
agrees with this postulate, and only Astrap and his group still 
maintain that proactivator is a discrete substance. He bases his 
statement on the findings of different ratios of proactivator to 
plasminogen in various body fluids. Complicating this interpre¬ 
tation is the fact that the assays involve many complex reactions. 
The following activation scheme has been suggested by Kline 
(28), who studied fibrinolysis in purified and "impure11 clots, to 
summarize the feelings of investigators in the field of fibrino¬ 
lysis today (except Astrup)% 
PLASMINOGEN 
(all species) 
PLASMINOGEN + SK-► ACTIVATOR---► 
(human) (SK-X) 
PLASMXN 
In the above reaction, it can be seen that, in the case of 
human plasminogen, the reaction is autocatalytic. Once a small 
amount of plasminogen has reacted with SK to form the universal 
activator (SK-X), this will convert the remainder of the plas¬ 
minogen to plasmin. 
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II. THE USE OF SYNTHETIC SUBSTRATES FOR FIBRINOLYTIC ASSAY 
In 1954 Kline studied the proteolytic activity of plasmin by 
observing the speed with which it attacked casein (27). He noticed 
that when plasminogen purified by his method (26) was incubated with 
SK at pH 7.4, the activity obtained was far below that which occur¬ 
red if casein were present during the activation. He found that the 
activity which appeared was directly related to the concentration of 
casein present during the activation. This presented a very inter¬ 
esting possibility: perhaps the casein present during the activation 
was exerting a "protective action." If so, less SK would be needed 
to activate a given amount of plasminogen. Since it was the toxicity 
of SK which was the main obstacle to the in-vivo use of plasmin (25, 
17, 45), this might have been quite an important discovery. 
Since the presence of casein rendered the preparation unsuit¬ 
able for repeated intravenous administration, other substrates of 
plasmin were tested for protective action. In 1954, Troll, Sherry, 
and Wachman reported that certain esterified basic amino acids were 
split by plasmin (45). Kline investigated the protective actions 
of arginine methyl ester, arginine ethyl ester, and lysine ethyl 
ester (LEE). Although all three showed definite protective action, 
the arginine esters formen non-elutable precipitates during the acti¬ 
vation; the slight precipitate formed by LEE was easily removed. 
Additional experiments, performed to demonstrate the protective action 
of LEE in fibrinolytic and proteolytic systems showed that the 
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protected solutions had about four times the fibrinolytic and 
proteolytic activity of the non-protected. 
A recent report (January 1957) by Schultz, Moorman, Matoush, 
and Lincoln (40) described an attempt to determine a normal level 
of enzyme activity in human plasma as measured by the lysis of 
LEE and tosyl arginine methyl ester. They noted marked variations 
in the activity of their controls, but could demonstrate no dif¬ 
ference in the proteolytic activity of normal blood compared to 
blood with marked fibrinolytic activity. They concluded that syn¬ 
thetic substrate assays are not suited for the clinical measurement 
of fibrinolytic activity. 
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III. PURPOSE OF THE PRESENT INVESTIGATION 
At the time this work was begun (1955), the intravenous ad¬ 
ministration of SK activated plasminogen to humans was quite dan¬ 
gerous, due to the toxic effects of SK (23, 17, 43). The demon¬ 
stration by Kline that the presence of a plasmin substrate such as 
LEE during the activation of plasminogen by SK would enhance the 
proteolytic effect of the enzyme suggested an approach to the prob¬ 
lem of SK toxicity. In addition, Christensen5s observation that 
the presence of another plasmin substrate, fibrinogen, would enhance 
the fibrinolytic effect of the enzyme (3), lent an added impetus 
to the investigation. If T.EF. were to show the same protection in 
a fibrinolytic system that it did in a proteolytic system, then the 
amount of SK needed to activate a given amount of plasminogen 
could be reduced in proportion to the protection afforded by T.EE 
during the activation. This might well result in the production 
of a compound with potent fibrinolytic effects, but with SK con¬ 
centrations low enough to be in a safe range for human intravenous 
administration. 
In this investigation, the effect of the presence of LEE 
during the activation of plasminogen by SK was studied, and some 
in-vivo studies of the enzyme so produced were performed. Evi¬ 
dence was also sought concerning the possibility that plasmin 
exerts both a fibrinolytic and a proteolytic action. 
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MATERIALS AM) METHODS 
X. WITH "IMPURE" AND "PARTIALLY PURIFIED" CLOTS AS SUBSTRATES, 
MATERIALS! 
Veronal Buffer, 
0,05 M pH 7.8 
Plasminogen. 
Purified according to the method of Kline (27). To 
dissolve, 5.5 ml of distilled water and one drop of 
1 N HGl were added to 20 mg of powdered plasminogen. 
Then enough 1 N NaOH was added to first form a milky 
precipitate, and just to re-dissolve it, at about 
pH 8.7. Enough distilled water to bring the final 
volume to 5 ml was added, resulting in a final plas¬ 
minogen concentration of 4 mg/ml. 
Streptokinase. 
Kindly supplied by Lederle Laboratories as Strepto¬ 
kinase - Streptodornase (Varidase). The preparation 
used contained 4,700 SK units/mg of powder. It was 
dissolved in veronal buffer to various concentrations. 
Fibrinogen. 
1). Armour Fraction Is 80 mg of powder containing about 
25% clottable fibrinogen were dissolved in 10 ml of 
buffer. This produced a final concentration of 
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about 0*2%, 
2). Three times (5x) purified fibrinogens Armour 
Fraction I purified three times according to the 
procedure of Laid (29), Sixty-five mg of 5x 
purified fibrinogen plus 120 mg of KCl were dis¬ 
solved in 20 ml of buffer. This solution con™ 
tained 2 mg/ml of fibrinogen (0.2$) and 7.6 mg/ml 
of KCl (0.1 M). 
Thrombin. (Upjohn) 
The contents of one vial were dissolved in 5 ml of 
buffer plus 5 ml of glycerol, resulting in a concen¬ 
tration of 100 U/ml. 
lysine Ethyl Ester .(.LEE), 
The powder was dissolved in 0.05 M veronal buffer or 
phosphate buffer to varying concentrations, and neutral¬ 
ized with 1 N NaOH. 
NOTE: All reagents, except thrombin, were dissolved fresh 
daily. The thrombin was refrigerated when not in use. 
Animals. 
Two mongrel male dogs, weighing 14 and 14.5 Kg. 
METHODS: 
I. Activation of Plasminogen with SK 
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0*5 ml of plasminogen, 0,5 ml of SK, and 1,0 ml of 
buffer (or LEE) were incubated at 57° C. for five minutes. Some 
batches were activated in the presence of fibrinogen. 
II. Assay for Fibrinolytic Activity. 
This test consisted of forming a clot in the pres¬ 
ence of active enzyme (plasmin) and observing the time required 
for lysis of the clot. It was arranged as follows% 
TUBE A 
.100$ 
o 
40$ 
O 
£0$ 
o 
TUBE B o o o 
TUBE A 
100$ 0.5 ml enzyme 0,5 ml buffer 0,04 ml thrombin 
40$ 0,2 ml enzyme 0.8 ml buffer 0.C4 ml thrombin 
20$ 0.1 ml enzyme 0.9 ml buffer 0.04 ml thrombin 
TUBE B 
0.5 ml fibrinogen and 0.5 ml buffer (all tubes). 
NOTE: In some tests, LEE was substituted for buffer In tube A 
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METHOD; 
Tubes A and B (in each of the three percentages) were mixed 
by pouring their contents back and forth three times, and then 
were incubated at 57° C® The tubes were allowed to remain in the 
water bath without agitation for two minutesj during this time 
the clots had formed* They were then checked by inversion at 
thirty second intervals to determine the presence of fibrinolysis 
which was defined as that point at which the cloudy gel in the 
tube turned into a clear sol — the end point was fairly sharp. 
The enzyme was diluted until a concentration was obtained which 
would produce lysis in the 100$ tube in about five minutes. 
All determinations were done at least in duplicate. 
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II, WITH A "PUKE" CLOT AS SUBSTRATE. 
MATERIALS; 
Plasminogen. 
4 mg/ml (in solution), 
LTTE 
75 mg/ml in phosphate buffer (stock solution). 
Phosphate buffer. 
0.C5 M pH 7.8. 
80 mg/wl (stock solution) 
Fibrinogen. 
Freeze-thaw preparation. Prepared by Dr. D. I.. Kline 
according to the method of Ware, Guest, and Seegers (47). 
The fibrinogen was an 0.4$ solution in saline, prepared 
from human plasma. It was thawed at 48°-§Q° C. 
Thrombin solution. 
Prepared by Dr. D. L. Kline. (100 U/ml). 
METHOD: 
I. ACTIVATION OF ENZYME: 
0.5 ml of plasminogen (2 mg) was incubated with 
0.1 ml of SK (varying concentrations) and 0.4 ml of 
buffer at 37° C for five minutes. In later parts of 
the experiment (Assay B), varying amounts of T.FF: were 
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substituted for buffer during the activation# 
II, ASSAI «A": 
TUBE A TUBE B 
0,2 ml activated enzyme 0,5 ml fibrinogen 
0,5 ml phosphate buffer 
0,02 ml thrombin 
The Assay was performed as previously described (page 16)* 
III* ASSAY "B": 
1) , Effect of adding LEE to activating solution! 
From 0,03 to 30 mg of LEE were substituted for 
buffer in the activation of the enzyme. 
2) , Since only 0,2 ml of activated enzyme were used in 
the assay, only 2C$ of the LEE added in (1) was 
present in the final assay. The amount of LEE 
lost in taking only 0,2 ml of activated enzyme 
(80$ of IFF added to the activating solution) was 
added back to the assay in place of the 0.3 ml 
of buffer 
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EXPERIMENTAL 
I. THE INFLUENCE OF SK CONCENTRATION ON THE LYSIS TIME (NO LEE PRESENT) 
The first few parts of this investigation were concerned with 
the evaluation of the "protective effect" which LEE might offer during 
the activation of plasminogen by SK, as measured by the lysis of a 
standard clot. The initial step was to activate plasminogen with 
SK, without any T.EE present, in order to obtain values which could 
then be used as controls for evaluating the effect of the presence 
of LEE in the activating mixture. From these values a concentration 
of SK could be chosen which would permit the demonstration of any 
protective action in the presence of LEE. 
With a constant plasminogen concentration of 1 mg/ml, the 
concentration of SK in the activating mixture was varied from 
0.001 mg/ml to 2.0 mg/ml. The dilutions of activated enzyme 
necessary to produce lysis in about five minutes were determined. 
This five minute point was obtained from curves determined from 
three different concentrations of the enzyme being tested. 
The log of the lysis time, in seconds, was plotted against 
the log of the concentration of SK in each tube. The strongest 
concentration was designated as "100$”. 
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TABLE 1 
INITIAL CONCENTRATION DILUTION OF 
ACTIVATED 
AVERAGE LYSIS 
TIME OF 
LOG AVERAGE 
LYSIS TIME 
PLASMINOGEN MZML xx&jm (SECONDS) 
2.0 1.0 1:50 295 2.47 
1.5 1.0 1:50 350 2.52 
1.0 l.C 1,50 470 2.67 
0.5 l.C 1:50 565 2.75 
0.04 1.0 1:2 405 2,59 
0.02 1.0 
— 
285 2.45 
0.01 l.C 
—— 
360 2.56 
0.001 1,0 530 2.52 
TABLE I: The influence of the SK concentration on the lysis time. 
RESULTSi SEE TABLE I and GRAPHS I and II. 
A straight line was obtained when the above method of plotting 
was employed, for each concentration of SK used in the activating 
mixture. The slopes of the lines obtained with various SK concen¬ 
trations were equal (See GRAPH I) except when the SK concentration 
was 0.04 mg/mX or less. 
As can be seen in TABLE I, the fibrinolytic activity increased 
as more SK was used. The highest concentration of SK used (2 mg/mX) 
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produced the dissolution of a clot containing 0.02 mg of plas¬ 
minogen/ ml in five minutes. This concentration was therefore 
used in the following experiments, since it would permit an T.FTF, 
effect to be demonstrated either in a shortened lysis time or 
in a decreased requirement for SK. 
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GRAPH I. THE INFLUENCE OF SK CONCENTRATION ON LYSIS TIME. 
The concentrations of SK and plasminogen used in this graph 
represent those in the activating mixture. These concentra¬ 
tions were further diluted to run the assay, as is shown in 
the preceding TABLE I. 
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II, THE ADDITION OF LEE TO THE ACTIVATING MIXTURE, 
Having determined the lysis time of a clot which was acted 
upon by a given amount of plasminogen activated by varied amounts 
of SK, the next step was to select one value of SK and to see if 
the addition of LEE to the activating mixture would decrease the 
lysis time of a clot, exerting a protective action as Kline had 
shown it would do with a casein substrate. 
With a plasminogen concentration of 1 mg/ml, and an SK 
concentration of 2 mg/ml, the concentration of LEE added to the 
activating mixture was varied over & wide range (0,16 to 25 mg/ml)9 
The log of the lysis time (in seconds) was plotted against the 
dilution of the enzyme (activated in the presence of LEE) for 
each LF,E concentration. 
RESULTS: SEE TABLE II and GRAPHS III and IV. 
When Kline studied the activation of plasminogen by SK in 
the presence of LEE, and noted its increased effect in the proteo«= 
lysis of casein, he found an LEE concentration of 15 mg/mg of 
enzyme to be optimal (28), It is of interest, therefore, that 
in the present experiment large amounts of LEE actually increased 
the lysis time of a standard fibrin clot. Indeed, as can be seen 
in GRAPHS III and I?, only an LEE concentration of 0,5125 mg/ml 
produced a decrease in lysis time as compared with that obtained 
~ -• ■■ .-V 'io i:Ti Cu : rv,-v 
’ ,f' '•>? ' -' ■■■■ -•»’ . ' : ■. . i- y- \ .i.r «./ ry -yr 
■ '• . . ' £a ■ . 
- ■■ t cl . : ■ U . 
■■■■■'. i- ter /•", j 3 ?x gjfc^r 
• ,;r 5: T'C ' o." . ;• : •• U... 
'V: ;.;fe sc JU.-.VS. •• ■ L -? 
©&■ t£n\$s S “io aoJ:4,jw*na»ixoo 
■ r 48 1SVO &9XS0V 38V frVSrJxtffcjr 'y->5 -T., v' 
hjaisgs hrj, oaooea at) md& ats^ &&S m 30X nt£S 
■■" v - -tonscmv: !?eojsrlfoa) &r%sae to f: U •. • i 
" ba ■ ■.• 
:tea *:.v ba£h0a sail! amM 
■ ■ , ■ « 
• • ■■■. ' J .'■; • ••••: ,. J.■y; ; - 
• (8S) Xsi5 
l2:* ws'Z&i %LL&s?J,o& 35U to ■stgrmX teamit&aqxe tet&ssiq edt at 
lie(Jtt &nhu$t& a to m£$ ?.&zxl «*{;* 
^i'laq.Tos as ©fixitf fil eo&Q’io^b & j&©wbo*tq 
in the absence of LEE. It appeared as if the presence of an LEE 
concentration of 5,0 mg/ml or less had no demonstrable effect on 
the lysis time. Concentrations of LEE greater than 5.0 mg/ml 
actually appeared to inhibit fibrinolysis. Since an LEE concen¬ 
tration of 0.5125 mg/ml only showed a questionable ’'protective 
effect”, as evidenced by a slight decrease in lysis time, it was 
decided to investigate further the effect of this concentration 
of LEE in the activating mixture, to see if the SK requirement 
might have been decreased, even though the lysis time had not 
been markedly affected. 
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TABLE II 
LEE CONG. 
mm^ ill Itl6 ls84 1^58, AjlIOM lilQ9,6 
25 900 715 585 545 670 865 900 
15 558 661 415 381 555 855 90G 
10 505 250 250 240 540 600 900 
5 245 185 185 210 280 555 900 
2.5 255 185 170 210 350 520 900 
1.25 195 175 155 205 350 670 900 
0.625 180 160 155 190 295 480 780 
0.5 150 165 185 230 565 750 900 
0.5125 120= 120=* 150 195 510 495 900 
0.15625 160 175 170 255 450 830 900 
0 145 155 185 230 365 610 900 
LISTS TIME FOR REPRESENTATIVE DILUTIONS (SECONDS) 
TABLE II, Demonstrating the lysis time in seconds for varied 
dilutions of the activating mixture as the T.EE concentra¬ 
tion was varied from 0 to 25 mg/mX. The concentrations 
of SK and plasminogen were 2 mg/mX and 1 mg/ml respectively. 
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III, THE DETERMINATION OF AN OPTIMAL SK CONCENTRATION 
(IN THE PRESENCE OF LEE) 
The striking effect of the presence of LKF. on the proteo¬ 
lysis of casein had not been duplicated with a fibrin clot as sub¬ 
strate in the last experiment. Although the presence of LEE in 
the activating mixture did not increase the fibrinolytic activity 
of the enzyme by decreasing the time required for lysis of a fibrin 
clot, there still remained the possibility that the presence of 
LEE might permit a decrease of the SK concentration without a dim¬ 
inution of the fibrinolytic activity of the enzyme. Thus, perhaps 
the same fibrinolytic activity could be obtained with less SK used 
in the activation of plasminogen. It was decided to observe the 
effect of varied SK concentrations used to activate plasminogen 
in the presence of LEE, 
With the plasminogen concentration kept constant at 1 mg/ml, 
and the LEE concentration constant at the previously determined 
optimal level of 0,5125 mg/ml, the SK concentration was varied 
from 0.02 mg/ml to 2 mg/ml to determine the concentration of SK 
which would result in the fastest lysis time. 
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TABLE III 
SK CONC. LYSIS TIME FOR REPRESENTATIVE DILUTIONS (SECONDS) 
Xmg/mlJ 
UNDIL. 1;4 1:16 1:54 1*256 1:1024 1:4096 
0 NO L ISIS 
0.02 190 340 585 785 900 
0.05 190 290 490 745 900 
0.1 220 300 425 670 900 
0.5 120 160 225 390 545 900 
1.0 120 130 165 205 315 640 785 
2.0 120 120 150 195 310 495 900 
TABLE III. Demonstrating the lysis time in seconds for 
representative dilutions of the activating mixture as 
the SK concentration was varied from 0 to 2 mg/ml. 
The concentrations of plasminogen and LEE were 1 mg/ml 
and 0.3125 mg/ml respectively. 
RESULTS: SEE TABLE III and GRAPHS V and VI. 
Fastest lysis times were obtained with SK concentrations of 
1 mg/ml and 2 mg/ml. The two concentrations resulted in approxi¬ 
mately the same lysis time, suggesting that the larger concentra¬ 
tion was in excess of the amount of SK needed to activate all of 
the plasminogen present. It should be noted that this was the 
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same concentration (2 mg/ml) need in the previous testing of the 
effect of the presence of LEE during the activation of the enzyme. 
This would suggest that the previous results showing lack of pro¬ 
tect ion” were valid, LEE did not produce a decrease in the lysis 
time of a fibrin elot? nor did it permit the demonstration of a 
decrease in the amount of SK required to produce a given level of 
fibrinolytic activity. 
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IV. A RE-EVALUATION OF THE EFFECT OF LEE UNDER OPTIMAL CONDITIONS. 
The results obtained up to this point had been quite dis¬ 
appointing — there was little or no "protective action9’ exhibited 
by T.F.E during the SK activation of plasminogen. It was felt 
necessary to repeat the experiment using "optimal” conditions to 
observe whether some mistake in technique might have produced the 
unexpected results. 
With plasminogen and SK concentrations of 1 mg/ml each, the 
effect of the presence of 0.3125 mg/ml of LEE during the activa¬ 
tion of plasminogen by SK was restudied. 
RESULTS; SEE TABLE IV and GRAPH VII. 
Once again, only minimal decrease in lysis time was noted on 
addition of LEE to the activation mixture. It was concluded that, 
under the conditions used in this experiment, TEE did not show any 
"protective action" in a fibrinolytic system, either by decreasing 
the lysis time or by reducing the SK requirement. 
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TABLE IV 
LYSIS TIME FOR REPRESENTATIVE DILUTIONS (SECONDS) 
UNDIL* 2jQA JoUBft 2Mm 
(A) 120 130 165 205 315 640 785 
(B) 125 160 175 235 355 760 900 
(C) 150 175 235 285 430 900 
TABLE IV* Representing the lysis time in seconds for representative 
dilutions of the activating mixture with the LEE concentration 
varied as follows? 
(A) Previously determined values (see GRAPH V and TABLE 
III) for an LEE concentration of 0*3125 mg/ml* 
(B) LEE concentration? 0*3125 mg/ml. 
(C) No LEE. 
In all of the above determinations, the concentrations of SK and 
plasminogen were each 1 mg/ml. 
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V, A COMPARISON OF ARMOUR FRACTION I AND 5x PURIFIED FIBRINOGEN. 
Since, according to the previous results, T.EE had shown little, 
if ary, protective action, it was felt that further investigation 
of the fibrinolytic system itself was in order. The presence of a 
contaminating bovine plasminogen in the Armour Fraction I has al¬ 
ready been mentioned (cf. INTRODUCTION, page 8). In order to re¬ 
move this contaminant, and thus to evaluate better the ^protective 
action” of LEE on a relatively '"pure” system, the fibrinogen had 
been purified three times by the Laki procedure (29), The inability 
to demonstrate a protective effect of LEE suggested that the puri¬ 
fication of the fibrinogen might have removed a factor whose presence 
was necessary for LEE to demonstrate its protective action during 
the activation of plasminogen by SK. Therefore, the fibrinolytic 
activity of plasmin on both Armour Fraction I and 5x purified 
fibrinogen was studied both with and without LEE present during 
the activation. 
RESULTS; SEE TABLE Y. 
There was no constantly demonstrable difference in the lysis 
time obtained with the two types of fibrinogen. The presence of 
LEE in either system had no appreciable effect. 
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TABLE V 
TEST # LYSIS Tir.TE IN SECONDS 
ARMOUR FR» I ARMOUR FR» I 5x PUR. 5x PUR. 
NO LEE WITH LEE NO LEE WITH LEE 
1 295 265 290 285 
2 330 265 300 255 
3 515 310 315 310 
4 310 270 
5 300 275 
6 205 255 265 265 
7 250 255 265 280 
•i 
AVERAGE 284 270 283 279 
TABLE V. A comparison of Armour Fraction I and 3x purified 
fibrinogen with and without the presence of LEE* The 
concentrations used were as follows; SK and Plasminogen 
were 1 mg/ml each, LEE (when noted) was 0,3125 mg/mX, 
In each case the enzyme was diluted 1;64, 
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VI. THE EFFECT OF INCUBATION TIME ON THE POTENCY OF THE ENZYME. 
It was thought that perhaps the SK-plasminogen mixture was 
not being allowed to incubate long enough, and that sub-optimal 
amounts of plasmin might be forming. Enzymes incubated for the 
usual five minutes were compared with those incubated for one and 
six hours. There were various combinations of enzyme activated 
with and without LEE, and with substrates containing Armour 
Fraction I and 3x purified fibrinogen. 
RESULTS: SEE TABLE VI. 
Incubation of the enzyme for more than five minutes resulted 
in a gradual diminution of fibrinolytic activity, regardless of 
the presence of LEE or the purity of the fibrinogen. 
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TABLE VI 
INCUBATION LYSIS TIME IN SECONDS 
TIME 
ARMOUR FR. I 
NO LEE 
ARMOUR FR, I 
WITH LEE NO LEE 
5k-ERR* 
WITH LEE 
5 minutes 285 270 285 280 
1 hour 350 335 310 275 
6 hours 540 530 585 385 
TABLE ¥1, Demonstrating the effect of incubation on the lysis 
time of clots made with either Armour Fraction I or 5x 
purified fibrinogen, with and without LEE present during 
the activation of the enzyme. The concentrations used were 
as followss SK and plasminogen were 1 mg/ml each, T.F.E 
(when noted) was 0,3125 mg/ml. In each case the enzyme was 
diluted Is64, 
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VII, THE EFFECT OF THE PRESENCE OF FIBRINOGEN DURING THE ACTIVATION. 
It was decided to attempt to investigate the statement of 
Christensen (5) in which he noted that plasminogen activated with 
SK in the presence of fibrinogen was far more fibrinolytic than 
that separately activated, then added to the substrate. It was 
the latter method which had been employed in the previous experi¬ 
ments in this paper, since it was felt that this would ultimately 
be the method used to prepare materials for in-vivo use. 
Both Armour Fraction I and 3x purified fibrinogen were used. 
RESULTSi SEE TABLE VII. 
The presence of substrate, either Armour Fraction I or 3x 
purified fibrinogen, during the activation had no demonstrable 
effect on the lysis time. If anything, the lysis time was slightly- 
increased when the substrate was present during the activation 
of the enzyme. Thus, Christensen’s report of the increase in 
lytic activity when the substrate is present during the activa¬ 
tion was not confirmed. 
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TABLE VII 
LISTS TIME 
PKE-ACTXVATED WITH FIBRINOGEN 
300 560 
310 375 
185 225 
195 225 
IN SECONDS 
ACTIVATED WITHOUT FIBRINOGEN 
ARMOUR FR, I 3x PUR, 
285 350 
215 200 
255 180 
TABLE VIX9 Demonstrating the effect of the presence of the sub¬ 
strate (fibrinogen) during the activation. The two sets 
of values were obtained on two different days. 
The concentrations used were as followss SK and plas¬ 
minogen concentrations were 2 mg/ml each. The plasminogen 
was diluted Is200, 
■ 
- - - •• « - . - •«-« - p - • f • “ •• • - • 
. . 
* .... :T- :: A • '♦.TV - '•% „ r . *»c -- , - —.— 
asa 0C5S 
eve OX?. 
oos. SIS 3SS SCI 
£3$: aex 
, • 
~83.f--T ;a& 'Hb jswrA DA ::;.o otc©?-; aitoDf£'u}'SS>ofloo e&T 
sir .■.■ . - .■ - s . 
44® 
VIII® AN ASSAY OF THE EFFECT OF LEE OH A PURE CLOT® 
This final part of the investigation was done a year after 
the preceding parts® During the elapsed time it had been found 
that the reaction between SK and plasminogen resulted in the pro¬ 
duction of not only plasmin but also activator (SK-X; cf. INTRO" 
DUCTION). It had also been shown that the clots previously used 
were "impure'*; that is, the fibrinogen and thrombin had been con¬ 
taminated by bovine plasminogen, which, in the presence of human 
plasminogen, was activated by SK (cf. INTRODUCTION). It was de¬ 
cided to test the activity of plasmin against a '•pure** clot 
(without contaminating bovine plasminogen), and to see whether 
LEE would exert any protective action. There were essentially 
two parts to this experiment. 
I. DETERMINATION OF AN OPTIMAL SK CONCENTRATION. 
With a plasminogen concentration of 4 mg/ml (0.5 ml was used 
in the activation), which corresponds to the concentration pre¬ 
viously used by Kline (28), the SK concentration was varied from 
0.01 to 16 mg/ml In the activating mixture. 
RESULTS! SEE TABLE VIII and GRAPH VIII. 
(1) High levels of SK inhibited clot lysis® 
(2) Optimal levels of SK (producing clot lysis in 
about three minutes) were found to be between 
0.5 and 0.05 mg/ml. 
. 
• s - - A- £ -I •• :vo-;' t-. yv.d &.;'J o ;fc£sq Lmll •:= f 
- i • 
. ->.!• ./ .\r. -•'! ■' ■}: Iq 13 -t&d :..e: drj..er. :k‘s & iCJ 
. 
v ' tolo ®rii t 'lrit Xiwo/ia sfesd o ?’.£,» a v? >M .'"rtITQuu 
, ... .o*zr:.S :-'in Xw%oal*i<t£t <*&$ te£ zi-,-% 
-'iiS at xdohi:’ salq wit.v.>d T.d 
del*: ”vM'.j ; •’ £ j ••:• a ■ tu mu. •. 7 1o \Hvl&t:2 eti# $s®j o«r ;• >c .:o 
■ , •;•■)' j\ ,• , ' ;=5.^17 aaJLvoci' ?nrd.: • v ••. a j r<‘> ■.•-’} 
■ si©?? &%ej£f . koISqm ^rld,o®^o,*q yos d-ssx© .blyow ASTI 
, ... 
. 
. . ■•■ 
..-.•. od s&txos ■ . . 
i«o^3t bety&v eaw noxj^idrtooxico X3 e;£d- , (3S) etxlSji %<$ 
. 
.Ill «S-m •:... 
• ' 
ala^I Solo saioudo’iq) 13 ' « .• ,v;' •, 
45 
TABLE 
TABLE VIII 
sKiflfUa 
activating sol*a) 
LYSIS TIME 
(seconds) 
0 720 
0.001 720 
0.01 420 
0.05 195 
0.1 240 
0.5 225 
1 350 
2 420 
4 720 
8 720 
16 720 
III, Determination of an optimal SK concentration. The 
substrate is a "pure” clot. The plasminogen concentration 
is 2 mg/ml. 
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II* THE EFFECT OF LEE ON A PURE CLOT. 
With a sub-optimal SK concentration (O.OOl mg/mX) and a 
decreased plasminogen concentration (1 mg/rul) the effect of TEE 
was teste as followsj 
(A) LEE (0.05 to 30 mg/ml) was substituted for buffer In 
the activating mixture, 
RESULT; LEE produced an Increase in lysis time 
proportional to the T.FF. concentration. 
(B) LEE was also added to the assays in an amount sufficient 
to maintain the original IFF concentration during the 
assay. 
RESULT: An increase in lysis time was observed, 
even more so than with (A), 
SEE TABLE IX and GRAPH H, 
In summary, then, this study of lysis of a pure clot produced 
three interesting results; (1) The concentration of SK was critical 
with concentrations of SK above or below optimal, the fibrinolytic 
activity of the enzyme fell off sharply, (2) The presence of LEE 
during the activation of plasminogen by SK Inhibited the lysis of 
a "pure" fibrin clotj this inhibition was in direct proportion to 
the concentration of LF,F. in the activating mixture. (5) The amount 
of SK needed to activate a given amount plasminogen to produce 
lysis of a ’’pure” clot was far less than when an "impure” clot was 
used as the substrate 
. . 
3W Xu0*0) anZftmtr . ex. .-a /liv-i.' cV\ ■■ 
'" ' '■ -.S’. r. : ' \ •, e .... c at, • • . . • ■ .•■ • »: ■ b 
: „T :■ 1 .. fro . ;,7 
rti ieT$wd aatf (Jfc\§n 05 ©d* 50.0) 231 (.&} 
. ■ : :■ ■ 0: 
. 
o' XsiXoXd’TXoqo’Xi} 
dar/otaa - ^.-^Bsajs arid’ od bebba osla bsw 85U (g) 
:• f;: :' l- ! ,o SI I .L^tqx „o arid* : •.. siaui ci 
, 
’ 
ts d& 03 9*soffl nave 
... . ' : - 
' o . ' , . .... 
to noidBidnaojCroo ad® (X) sad’Xrman; srtfd’aatrad’si: eaodl 
■ x-i'S-1 ’ .Tlj -j. a vrclecf io ©rods 38 lo axroxisnrdjaooaoo .id’.nw 
33J lo 9ort ad® (S) ... jflto H©!t '©nngsae add’ io xdivid’oa 
"• r Sad Midori 20 Tgd’ na^ocrXesoXq lo aoid’xrxidos add soimfc 
rsoldTEoqo-jq doarxib al asw ftoidicfirLii airfd (dole a.c’xcfil "arauq* a 
dT (5) • eiwdx&a saxd’avid’oB odd ai asi lo tfoidjraddcsasoo 
:egocixnaBXQ 'i» dmooe nevig a odavlioa o.t bafeeon 23 
t r do£ 
. •• v "' o’ 
48 
TABLE IX 
W fW 
activating sol*hV 
LEE ADDED 
TO ASSAY fmg) 
LYSIS TIME 
(seconds) 
30 0 2580 
15 0 1740 
3 0 895 
0*5 0 675 
0.03 0 540 
0 0 380 
30 24 3600 / 
15 12 3600/ 
3 2.4 1350 
0.3 0.24 420 
0.03 0.024 435 
0 0 390 
The effect of TJTR on a ,8pure« clot assay* The concen¬ 
tration of SK was 0.001 mg/ml$ that of plasminogen was 
1 mg/ml. 
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IX. in VIVO TESTS OF LEE TOXICITY, 
In order to evaluate the toxicity of plasmin activated in the 
presence of LEE, the effect of the intravenous administration of 
0.2 ml/kg of the active enzyme was tested in two dogs. The solu¬ 
tion administered consisted of plasminogen (1 mg/ral), SK (1 mg/mX), 
and LEE (0.5125 mg/ml). After anesthetizing the dogs with 0.6 ml/kg 
of 0.6$ pentobarbital, 0.2 ml/kg of the solution was administered 
intravenously in an isotonic saline infusion infusion over a four 
hour period. Vital signs (temperature, pulse, respirations, blood 
pressure) and electrocardiogram (standard limb leads and precordial 
lead) were followed. The temperature was measured per rectum; 
blood pressure was measured by a manometer attached to a cannulated 
femoral artery. 
Blood was withdrawn from the external jugular vein near the 
beginning and end of the infusion, and, in the case of the first dog 
it was put into a citrate bottle; the blood of the second dog was 
allowed to clot. In the former it was centrifuged at 3000 rpm for 
thirty minutes, and the plasma was tested for fibrinolytic activity 
as previously described. In the latter, the clot was allowed to 
retract, and the serum was tested for fibrinolytic activity. 
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RESULTS; SEE GRAPH X 
The pulse, respirations, and blood pressure remained essen¬ 
tially unchanged. There was a moderate hyperpyrexia noted, with 
the rectal temperature rising from a baseline temperature of 103° F 
to 103,8° F in one case, and to 104.4° F in the other. Electro¬ 
cardiograms (kindly read by Dr. Louis Nahum) were within normal 
limits. 
The plasma or serum of the blood drawn at the beginning of 
the infusion had little, but measurable fibrinolytic activity. 
The plasma or serum of the blood drawn at the end of the infusion 
had marked fibrinolytic activity. 
It was concluded that the intravenous administration of 
plasminogen activated by SK in the presence of LEE, in amounts 
noted above, produced no demonstrable toxicity at levels which 
did produce fibrinolytic activity in the dog. 
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SUMMARY OF RESULTS 
At the time this investigation was begun, the intravenous 
administration of plasmin to humans was impractical due to the 
toxicity of the large amounts of SK needed to activate enough 
plasminogen to result in a potent fibrinolytic preparation. The 
discoveries by Christensen (1949) and Kline (1954) that the pres¬ 
ence of a plasmin substrate during the activation of plasminogen 
by SK would result in the appearance of markedly increased proteo¬ 
lytic activity formed the basis of this investigation. If Kline’s 
observations of the ’’protective action” of IFF, in a proteolytic 
system could be extended to include protection in a fibrinolytic 
system, the safety of the in-vivo use of plasmin would be greatly 
enhanced. This investigation was concerned with an attempt to 
demonstrate a ’’protective action” when IFF was present during the 
SK activation of plasminogen. It was hoped that either one of 
two effects might be observed if IFF were added to the activation 
mixturej (1) The fibrinolytic activity might be increased, thus 
permitting a decrease in the amount of SK needed to activate a 
given amount of plasminogen in order to obtain a given fibrino¬ 
lytic effect. (2) Although the lysis time remained unchanged, the 
SK requirement might be reduced, thus permitting a decrease in the 
amount of SK needed to activate plasminogen without a change in 
the lysis time. 
A review of the findings in this investigation indicates that 
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TFE did not exhibit any "protective action" in a fibrinolytic system. 
The results obtained in the individual experiments may be summarized 
as follows: 
I. EXPERIMENTS IN WHICH THE SUBSTRATE WAS A PARTIALLY PURIFIED 
CLOT. 
(1) Addition of small amounts of IFF, to the activating 
mixture had little or no effect on the lysis time of a clot. Addi¬ 
tion of large amounts of TFF. actually increased the lysis time of 
a standard fibrin clot, thus indicating a decrease in the fibrino¬ 
lytic activity of the enzyme. 
(2) The concentration of SK needed to activate a given 
amount of plasminogen in order to obtain a given fibrinolytic effect 
was not affected by the presence of TFE in the activating mixture. 
II. EXPERIMENTS IN WHICH THE SUBSTRATE WAS AN "IMPURE" CLOT. 
(1) The use of "impure" Armour Fraction I fibrinogen 
instead of fibrinogen which had been purified three times by the 
Laki procedure did not effect the lysis time of a clot which had 
been acted upon by enzyme activated in the presence of LEE. There¬ 
fore, the purification of the fibrinogen had n<st removed any factor, 
the presence «8f which might have been necessary in order for LEE to 
demonstrate its "protective action" during the activation of plas¬ 
minogen by SK. 
(2) The presence of IFF in the activating mixture 
did not necessitate a longer incubation of the enzyme during 
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activation. Indeed, incubation for longer than five minutes resul¬ 
ted in a gradual diminution of the fibrinolytic activity, regardless 
of the presence of TEE or the purity of the fibrinogen. 
(3) Christensenffs report of the rapid decline in pro¬ 
teolytic activity if the substrate were not present during the 
activation of plasminogen by SK was not confirmed, 
III. EXPERIMENTS IN WHICH THE SUBSTRATE WAS A "PURE” CLOT. 
(1) The presence of LEE during the activation of plas¬ 
minogen by SK actually decreased the fibrinolytic activity of the 
enzyme, as measured by its ability to lyse a "pure" clot. 
(2) The concentration of SK used was critical* with 
concentrations below 0.05 mg/ml or above 0.5 mg/ml the fibrinolytic 
effect of the enzyme decreased sharply. 
(3) The concentration of SK needed to activate a given 
amount of plasminogen was much less than when an "impure" clot was 
used as the substrate. 
IV. IN VIVO STUDIES OF LEE TOXICITY. 
(1) Enzyme which had been activated in the presence of 
LEE and which was administered intravenously to dogs at levels which 
produced demonstrable fibrinolytic activity did not produce any re¬ 
markable toxic effects as evidenced by little change in the dogs" 
vital signs and electrocardiograms. 
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DISCUSSION 
The difference between a "pure" and "impure" clot was not 
fully appreciated at the time this work was begun. But at present, 
it is believed that although lysis of a "pure" clot by SK acti¬ 
vated human plasminogen is a true measure of £lasmin activity, 
lysis of an"impure" clot is actually a measure of activator (SK-X). 
In order to explain this statement, reference is made to the cur¬ 
rently accepted scheme of activation: 
PLASMINOGEN 
(all species) 
PLASMINOGEN 
(human) 
+ SK-* ACTIVATOR 
(SK-X) 
PLASMIN 
The impurity in an "impure" clot was bovine plasminogen, which 
was present in both the bovine fibrinogen and. the bovine thrombin 
originally used. When a small amount of human plasminogen was acti¬ 
vated by SK, it produced activator (SK-X), which then activated large 
amounts of the bovine plasminogen present as impurities in the system. 
That such impurities were present is evidenced by the much greater 
amount of plasminogen (2 mg/ml) needed to lyse a "pure" clot than an 
"impure" one (0.0£ mg/ml) with optimal SK levels. It should be noted 
that the presence of a small amount of human plasminogen was necessary 
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in spite of a large amount of contaminating bovine plasminogen, 
since SIC acts almost entirely on human plasminogen, producing the 
universal activator which then activates the bovine plasminogen. 
The inability to demonstrate a difference in lysis time when three 
times purified fibrinogen was substituted for Armour Fraction I 
fibrinogen as a substrate would suggest that the bovine plasminogen 
was present almost entirely as an impurity in the thrombin. This 
has been confirmed in work by Kline (28). 
The inability to demonstrate a "protective action" of LEE in 
a fibrinolytic system is of great interest. In 1949, Christensen, 
working with a fibrinolytic system, stated that if plasminogen is 
not activated in the presence of a substrate the total protease 
activity will decline rapidly (5). He attributed this loss of 
activity to a two-fold effect of autodigestion and combination 
with a serum inhibitor. Five years later, Kline showed that the 
presence of casein, arginine methyl ester, arginine ethyl ester, or 
lysine ethyl ester (LEE) during the activation of plasminogen 
would result in an increased proteolytic activity of the enzyme 
as measured by the proteolysis of casein (27). The results of the 
present investigation suggest that the phenomenon of "protective 
action" exhibited by LEE in a proteolytic system cannot be extended 
to include activity in a fibrinolytic system. It is of interest to 
speculate concerning the cause of this marked difference in the 
action of LEE in proteolytic and fibrinolytic systems. 
It is possible that plasminogen is actually the precursor of 
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two separate enzymes, one proteolytic and the other fibrinolytic. 
Or perhaps plasminogen itself may be a mixture of fibrinolytic and 
proteolytic precursors. The suggestion that both fibrinolytic and 
proteolytic enzymes exist is not a new one. Cliffton, in 1952, 
demonstrated that administration of ACTH or cortisone would result 
in a marked increase in the proteolytic activity of the serum (6). 
True love, however, was unable to demonstrate any change in fibrino¬ 
lytic activity when these steroids were administered (48). In 
1955, Cliffton and Cannamela studied the fibrinolytic and proteo¬ 
lytic properties of various animal sera after their activation with 
SK or staphylokinase. They found that activated monkey plasmino¬ 
gen demonstrated high proteolytic but low proteolytic activity; 
exactly the opposite was true of the plasminogen of the horse. 
They concluded that "The results of these experiments suggest that 
fibrinolytic and proteolytic activity of the serum, as measured by 
these tests are not identical. Indeed, the results indicate that 
these activities may be due to distinct enzymes” (8). In another 
publication, Cliffton and Cannamela stated that slight modifications 
of the original method of preparation of plasminogen would result 
in the production of separate proteolytic and fibrinolytic enzymes 
(9). Kline, however, was unable to repeat these experiments, and 
suggested that the concentrations of plasmin used were too dilute to 
demonstrate proteolytic activity (27). In the present investiga¬ 
tion, the inability to demonstrate protection in a fibrinolytic 
system upon addition of a competing substrate (LEE or fibrinogen) 
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to the activation mixture, a property which does exist in a proteo¬ 
lytic system, might suggest that proteolysis and fibrinolysis are 
due to two distinct enzymes. 
It is probably not necessary, however, to postulate the 
existence of two distinct enzymes, one proteolytic and the other 
fibrinolytic. It is conceivable that only one proteolytic-fibrino¬ 
lytic enzyme exists, but that the strength of the enzyme-substrate 
complexes which it forms in proteolytic and fibrinolytic systems 
differs greatly. The action of LEE in the activating mixture would 
be the same in both systems: it would prevent the enzyme from under¬ 
going autodigestion by presenting it with a suitable substrate for 
proteolysis.* In this way, more enzyme would be spared than had 
there been no T.EE present to prevent the autodigestion. 
The combination of the LEE with the plasmin formed by the 
activation of plasminogen by SK might have resulted in an enzyme- 
substrate complex which was much stronger than that between plasmin 
and fibrin. Thus, the effect of the presence of LEE during acti¬ 
vation would have been to "tie up" the enzyme in a strong enzyme- 
substrate complex, not leaving much plasmin free to lyse the com¬ 
peting substrate, fibrin. As more LEE was added to the activating 
mixture, less plasmin would have been available for the lysis of 
fibrin. This difference in enzyme-substrate complex strengths was 
''Troll and Sherry had previously demonstrated that T,EE acts as a 
competitive inhibitor of plasmin (44, 45). 
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apparantly not a factor in the proteolytic system, for the plasmin- 
casein complex was at least hs strong as the plasmin-LEE complex. 
However, when fibrinogen was used as a ’’protective agent” it is 
probable that, like LEE, it formed an enzyme-substrate complex 
with the plasmin which was stronger than the plasmin-fibrin complex, 
so that no protection could be demonstrated. Indeed, it would 
appear that the enzyme-substrate complex which is formed when the 
plasmin substrate is a molecule (LEE, fibrinogen) is stronger than 
that which is formed with a more complex substrate (fibrin). Thus, 
the existence of only one enzyme need by postulated. This is in 
keeping with the demonstrations by Remmert and Cohen (38) and by 
Christensen and MacLeod (5) that the pH and temperature optimum 
for proteolytic and fibrinolytic stability and activities are iden¬ 
tical, and that the two activities increase proportionately during 
purification. 
In addition to the lack of a "protective action” of LEE in a 
fibrinolytic system, this investigation has demonstrated two other 
interesting properties of a fibrinolytic system. First, when work¬ 
ing with a pure clot it was shown that high levels of SE inhibited 
clot lysis. Christensen made a similar observation in 1949 (5). 
However, he stated that this inhibition only occurred when crude 
SK was used to activate the plasminogen, and that an increased lysis 
time could not be demonstrated with a more pure SK preparation. He 
postulated the presence of a protease inhibitor in the crude SK, 
which had been removed during the purification. It Is conceivable 
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that in the present investigation, the use of "pure" thrombin, 
plasminogen, and fibrinogen enabled quite small amounts of protease 
inhibitor to be demonstrated, and that, with a high SK concentra¬ 
tion, the effect of this inhibitor actually resulted in a decrease 
in proteolytic activity. 
The second interesting observation was the decreased need 
for SK to activate a given amount of plasminogen when the substrate 
was a "pure” clot® As was mentioned in the INTRODUCTION, the action 
of the SK is the stoichiometric reaction with human plasminogen to 
produce the universal activator (SK-X), which, in the case of a 
*5?ureM clot, enzymatically converts the remaining human plasminogen 
to plasmin. In an "impure" clot, the main substrate f«r SK-X is 
bovine plasminogen, which is also enzymatically converted to plasmin® 
It is conceivable that the conversion of bovine plasminogen to 
plasmin requires a greater amount of activator than does the con¬ 
version of human plasminogen to plasmin. If this were the case, 
more SK would be needed in the impure system. It is also possible 
that, along with the impurity of bovine plasminogen, the "impure" 
clot also contained an anti-SK. This, too, would necessitate larger 
amounts of SK in order to form sufficient activator to convert the 
bovine plasminogen to plasmin. 
In conclusion, this investigation has demonstrated that a 
phenomenon which occurs in a proteolytic system, namely the ability 
of LEE to protect the activation of plasminogen by SK, does not 
occur in a fibrinolytic system. This disparity is a reminder of 
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the complexities of the proteolytic and fibrinolytic systems. In 
many laboratories today, plasmin is being studied by observing its 
action on synthetic substrates, and conclusions are being drawn 
concerning its fibrinolytic properties. The results of this inves¬ 
tigation clearly indicate that such conclusions are not necessarily 
correct. The recent (1957) evaluation of synthetic substrate 
methods for clinical determination of fibrinolysis by Schultz et 
al (40) has re-affirmed the statement that such methods are not 
suitable for the clinical demonstration of fibrinolytic activity. 
Only those properties of plasmin which have been demonstrated by 
the use of fibrin as a plasmin substrate can be accepted as being 
truly descriptive of a fibrinolytic system. 
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SUMMARY 
1, The demonstration by Kline that the presence of T-FP during the 
activation of plasminogen by SK would increased in increased proteo¬ 
lysis of casein could not be extended to include protection in a 
fibrinolytic system. Small concentrations of LEE had little or no 
effect on the lysis time of a clot; large concentrations of T/F1F. 
actually inhibited clot lysis, 
2, Christensen*s statement that, in a fibrinolytic system, the pres¬ 
ence fibrinogen during the activation of plasminogen by SK is 
essential to obtain optimal protease activity could not be confirmed, 
3, High levels of SK inhibited clot lysis, 
4, Less SK was needed to activate plasminogen when the substrate was 
a ”pure11 than an "impure” clot, 
5, Possible explanations of the differences noted between the fibrino¬ 
lytic and proteolytic systems are discussed, A difference in the 
strength of the enzyme-substrate complexes in the two systems is 
postulated as the most plausible explanation. 
6, Conclusions drawn from observations of the action of plasmin in 
a proteolytic system should not be extended to include its activity 
as a fibrinolytic agent. 
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